Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:2244-2249
Published online before print April 21, 2003, doi: 10.1161/01.CIR.0000065604.56839.18
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/17/2244    most recent
01.CIR.0000065604.56839.18v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phillips, J. W.
Right arrow Articles by Sarembock, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillips, J. W.
Right arrow Articles by Sarembock, I. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Mechanism of atherosclerosis/growth factors
Right arrowRelated Article

(Circulation. 2003;107:2244.)
© 2003 American Heart Association, Inc.


Basic Science Reports

Single Injection of P-Selectin or P-Selectin Glycoprotein Ligand-1 Monoclonal Antibody Blocks Neointima Formation After Arterial Injury in Apolipoprotein E-Deficient Mice

J. William Phillips, MD; Kurt G. Barringhaus, MD; John M. Sanders, BS; Sean E. Hesselbacher, BS; Ann C. Czarnik, BS; David Manka, PhD; Dietmar Vestweber, PhD; Klaus Ley, MD; Ian J. Sarembock, MB, ChB, MD

From the Department of Medicine, Cardiovascular Division (J.W.P., K.G.B., J.M.S., S.E.H., A.C.C., I.J.S.), the Cardiovascular Research Center (K.L., I.J.S.), and the Department of Biomedical Engineering (D.M., K.L.), University of Virginia Health System, Charlottesville; and the University of Münster, Münster, Germany (D.V.). Dr Manka is currently at the Center for Transgene Technology and Gene Therapy, Leuven, Belgium.

Correspondence to Ian J. Sarembock, MD, Cardiovascular Division, University of Virginia Health System, Box 800158, Charlottesville, VA 22908-0158. E-mail ijs4s{at}virginia.edu

Background— Emerging data suggest that P-selectin, by controlling adhesion of white blood cells, may be important in limiting the response to vascular injury.

Methods and Results— We tested the hypothesis that transient inhibition of P-selectin with either anti-P-selectin monoclonal antibody (mAb) or anti-P-selectin glycoprotein ligand-1 (PSGL-1) mAb would reduce neointima formation in the setting of carotid denudation injury in atherosclerosis-prone apolipoprotein E-/- mice. Neointima formation at 28 days was reduced significantly, by 50% or 80%, by a single injection on the day of injury of 100 or 200 µg P-selectin mAb RB 40.34 and by 55% by a single injection of 100 µg PSGL-1 mAb 4RA10 (P<=0.005). In addition, there was a significant reduction in neointimal macrophage content.

Conclusions— These findings demonstrate that transient P-selectin or PSGL-1 blockade at the time of arterial injury significantly limits plaque macrophage content and neointima formation in a dose-dependent manner after carotid denudation injury in apolipoprotein E-/- mice.


Key Words: antibodies • arteries • atherosclerosis • cell adhesion molecules • inflammation


Related Article:

Inflammation, Neointimal Hyperplasia, and Restenosis: As the Leukocytes Roll, the Arteries Thicken
Prediman K. Shah
Circulation 2003 107: 2175-2177. [Full Text]



This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. P. Reiner, C. S. Carlson, B. Thyagarajan, M. J. Rieder, J. F. Polak, D. S. Siscovick, D. A. Nickerson, D. R. Jacobs Jr, and M. D. Gross
Soluble P-Selectin, SELP Polymorphisms, and Atherosclerotic Risk in European-American and African-African Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1549 - 1555.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. W. Bedard, V. Clerin, N. Sushkova, B. Tchernychev, T. Antrilli, C. Resmini, J. C. Keith Jr., J. K. Hennan, N. Kaila, S. DeBernardo, et al.
Characterization of the Novel P-Selectin Inhibitor PSI-697 [2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] Quinoline-4-carboxylic acid] in Vitro and in Rodent Models of Vascular Inflammation and Thrombosis
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 497 - 506.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. von Hundelshausen and C. Weber
Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease
Circ. Res., January 5, 2007; 100(1): 27 - 40.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Hanninen, R. Nurmela, M. Maksimow, J. Heino, S. Jalkanen, and C. Kurts
Islet {beta}-Cell-Specific T Cells Can Use Different Homing Mechanisms to Infiltrate and Destroy Pancreatic Islets
Am. J. Pathol., January 1, 2007; 170(1): 240 - 250.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Iwaki, M. J. Sandoval-Cooper, M. Brechmann, V. A. Ploplis, and F. J. Castellino
A fibrinogen deficiency accelerates the initiation of LDL cholesterol-driven atherosclerosis via thrombin generation and platelet activation in genetically predisposed mice
Blood, May 15, 2006; 107(10): 3883 - 3891.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. A. Korshunov, T. A. Nikonenko, V. A. Tkachuk, A. Brooks, and B. C. Berk
Interleukin-18 and Macrophage Migration Inhibitory Factor Are Associated With Increased Carotid Intima-Media Thickening
Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 295 - 300.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K.J. Woollard, D. Kling, S. Kulkarni, A.M. Dart, S. Jackson, and J. Chin-Dusting
Raised Plasma Soluble P-Selectin in Peripheral Arterial Occlusive Disease Enhances Leukocyte Adhesion
Circ. Res., January 6, 2006; 98(1): 149 - 156.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Pei, J. Gu, P.-R. Thimmalapura, A. Mison, and J. L. Nadler
Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E92 - E102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Li, J. M. Sanders, E. T. Phan, K. Ley, and I. J. Sarembock
Arterial Macrophages and Regenerating Endothelial Cells Express P-Selectin in Atherosclerosis-Prone Apolipoprotein E-Deficient Mice
Am. J. Pathol., December 1, 2005; 167(6): 1511 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. C. Ridger, P. G. Hellewell, and K. E. Norman
L- and P-Selectins Collaborate to Support Leukocyte Rolling in Vivo When High-Affinity P-Selectin-P-Selectin Glycoprotein Ligand-1 Interaction Is Inhibited
Am. J. Pathol., March 1, 2005; 166(3): 945 - 952.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Martinez, M. Joffraud, S. Giraud, B. Baisse, M. P. Bernimoulin, M. Schapira, and O. Spertini
Regulation of PSGL-1 Interactions with L-selectin, P-selectin, and E-selectin: ROLE OF HUMAN FUCOSYLTRANSFERASE-IV AND -VII
J. Biol. Chem., February 18, 2005; 280(7): 5378 - 5390.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Schober, A. Zernecke, E. A. Liehn, P. von Hundelshausen, S. Knarren, W. A. Kuziel, and C. Weber
Crucial Role of the CCL2/CCR2 Axis in Neointimal Hyperplasia After Arterial Injury in Hyperlipidemic Mice Involves Early Monocyte Recruitment and CCL2 Presentation on Platelets
Circ. Res., November 26, 2004; 95(11): 1125 - 1133.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. W. Homeister, A. Daugherty, and J. B. Lowe
{alpha}(1,3)Fucosyltransferases FucT-IV and FucT-VII Control Susceptibility to Atherosclerosis in Apolipoprotein E-/- Mice
Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1897 - 1903.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Yanaba, K. Komura, M. Horikawa, Y. Matsushita, K. Takehara, and S. Sato
P-selectin glycoprotein ligand-1 is required for the development of cutaneous vasculitis induced by immune complex deposition
J. Leukoc. Biol., August 1, 2004; 76(2): 374 - 382.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Manka, S. B. Forlow, J. M. Sanders, D. Hurwitz, D. K. Bennett, S. A. Green, K. Ley, and I. J. Sarembock
Critical Role of Platelet P-Selectin in the Response to Arterial Injury in Apolipoprotein-E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1124 - 1129.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. W. Phillips, K. G. Barringhaus, J. M. Sanders, Z. Yang, M. Chen, S. Hesselbacher, A. C. Czarnik, K. Ley, J. Nadler, and I. J. Sarembock
Rosiglitazone Reduces the Accelerated Neointima Formation After Arterial Injury in a Mouse Injury Model of Type 2 Diabetes
Circulation, October 21, 2003; 108(16): 1994 - 1999.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. K. Shah
Inflammation, Neointimal Hyperplasia, and Restenosis: As the Leukocytes Roll, the Arteries Thicken
Circulation, May 6, 2003; 107(17): 2175 - 2177.
[Full Text] [PDF]